RocGene (Beijing) Technology Co., Ltd.
Home · News ·
Blockbuster signing 丨 Rocgene was invited to participate in the Investment Beijing Global Summit and signed major investment projects on the spot
Jun 01,2023

On May 26, 2023, Guo Qiuzhen, General Manager of Rocgene, was invited to attend the "2023 Invest Beijing Global Summit", the first of its kind hosted by the Beijing Municipal Government.


With the theme of "Invest in Beijing, Win the Future", the summit was anchored in Beijing's strategic positioning as the national capital. Adhering to the "Five Initiatives" to integrate into the new development paradigm, it brought together senior representatives from Fortune 500 companies, large enterprises, investment institutions, business associations, as well as renowned experts and scholars. Highlighting high-level internationalization, cutting-edge industrial structure, focused promotion, and global connectivity, the summit fully demonstrated Beijing's development space and investment opportunities, creating a new window for Beijing's high-level opening-up and boosting the high-quality economic development of the capital. Sheng Qiuping, Vice Minister of Commerce, and Xia Linmao, Member of the Standing Committee and Executive Vice Mayor of Beijing Municipal Party Committee, attended and delivered speeches, while Sima Hong, Vice Mayor of Beijing, delivered a themed promotion of "Invest in Beijing".


Signing Ceremony


A grand signing ceremony was held at the event, where 39 major projects were successfully signed with a total value of 60.801 billion yuan. More than 600 guests from enterprises, governments, investment institutions and other sectors attended the summit.


As a key enterprise representative for Invest Beijing, Guo Qiuzhen, General Manager of Rocgene, signed an agreement on site with Liu Xiaodong, Executive Deputy District Mayor of Changping District, Beijing.



About Rocgene


Founded in 2016, Rocgene (Beijing) Technology Co., Ltd. is a core-tech-driven biotechnology company established by scientists and industry professionals. Rocgene is dedicated to translating cutting-edge life science technologies into clinically relevant medical research products, developing scientific research and molecular diagnostic products with independent intellectual property rights.


Rocgene has been accredited as a National High-Tech Enterprise and Zhongguancun High-Tech Enterprise, with a 10,000+ square meter clean production facility in Xuzhou High-Tech Zone. To date, the company has obtained 33 patents (17 invention patents, 9 utility model patents, 7 design patents) and 32 software copyrights. With the courage to surpass itself and the ambition to reach new heights, Rocgene aspires to become a forward-looking industry leader.



Rocgene Product Series


Latest News
Recommended Products
Continue to Company Website
Copyright © Rocgene (Beijing) Scientific Instruments Co., Ltd. - All Rights Powered by Bomin